Effect of rosuvastatin on serum levels of vaspin and visfatin in patients with CAD
Journal Title: Current Research: Cardiology - Year 2018, Vol 5, Issue 2
Abstract
AIM OF THE STUDY: Investigate the effect of Rosuvastatin on serum level of Vaspin and Visfatin in patients with CAD and determine the association between those adipokines and the severity of CAD. BACKGROUND: Statin treatment is considered one of the most effective strategies for the stabilization of atherosclerotic plaques and is related with enhancements in result in patients with coronary course diseases (CAD). Vaspin and Visfatin are adipokines involved in atherosclerosis progression. Objective: assess the impact of Rosuvastatin on serum level of Vaspin and Visfatin in patients with CAD and the relationship of those adipokines with seriousness of CAD. SETTING: Cardiology department, Tanta University Hospital, Egypt. METHODS: 80 patients who underwent coronary angiography due to symptoms of stable angina were enrolled in the study. 40 patients received Rosuvastatin 20 mg/day was compared to another 40 patients, as a control group, who refused statin treatment and preferred lifestyle modifications intervention. Main outcome measure: Clinical parameters, lipid profile, troponin I, high-sensitivity C-reactive protein (hs-CRP), Vaspin and Visfatin levels were assayed at the beginning and after 3 months. CAD severity was assessed by the Gensini score. RESULTS: Rosuvastatin administration considerably ameliorated most lipid parameters. Moreover, a significant increase of Vaspin and decrease of Visfatin concentrations (p<0.001) after Rosuvastatin treatment were observed (from 2.81 ± 0.74 ng/ml to 4.26 ± 0.76 ng/ml, from 4.62 ± 0.76 to 3.13 ± 0.98 respectively). There was a negative correlation between Vaspin and the Gensini score and positive correlation between Visfatin and Gensini score (r=-0.18 and r=0.19, p=0.05, respectively). CONCLUSION: Rousvastatin treatment reduces serum visfatin and increase serum vaspin levels in CAD patients. Those effects of Rousvastatin are of clinical importance.
Authors and Affiliations
Rehab Werida, Lamiaa Khedr MD, Alaa El-Sisi, Mai Salama MD
Keywords
Related Articles
- EP ID EP603127
- DOI -
- Views 41
- Downloads 0
Successful treatment of an acute sub-massive pulmonary embolism in a renal transplant patient with thrombolytic of low dosage in low infusion protocol
The Pulmonary embolism (PE) incidence is higher in patients with chronic kidney disease and renal transplantation (RT) than in general population. Thrombotic events are multifactorial in renal transplantation recipients...
Three-dimensional echocardiography of tricuspid valve for visualizing all the three leaflets
Three-dimensional echocardiography offers a unique opportunity of visualizing all the three leaflets of tricuspid valve in en-face view from transthoracic windows.It is very useful in localizing the position of the pacin...
Incidence and associated risk factors of cancer in patients after infective endocarditis hospitalization: A propensity score matched analysis
BACKGROUND: The relationship between infective endocarditis (IE) and malignancies had been reported. However, cancer development is multifactorial and mortality is high in IE survivors. We aimed to estimate the absolute...
Gated-SPECT myocardial perfusion imaging in women after acute coronary syndrome
OBJECTIVES: To assess the prognostic value of gated-SPECT myocardial perfusion imaging (MPI) in women after acute coronary syndrome (ACS), as well as to evaluate whether the intraventricular dyssynchrony shows any differ...
Cardiomyopathy in patients with Marfan syndrome and marfanoid habitus
OBJECTIVES: The term “Marfan cardiomyopathy” is used to indicate changes in left ventricular function in the absence of significant valvular pathology in Marfan syndrome. It is still unknown if there are any changes in c...